Our Resources | Association for Accessible Medicines

Apr 11, 2019 | Erica Klinger

AAM Code of Business Ethics

Jun 28, 2018 | Erica Klinger

2018 Generic Drug Access and Savings Report

Biosimilars Handbook - The New Frontier for Improved Access to Medicines: Biosimilars & Interchangeable Biologic Products

Apr 26, 2018 | Erica Klinger

Biosimilars Handbook

Apr 16, 2018 | Erica Klinger

2016 GPhA Savings and Access Report

AR17

Feb 12, 2018 | Erica Klinger

2017 AAM Annual Report

White Paper Ensuring the Future of Accessible Medicines in the U.S

Feb 9, 2018 | Erica Klinger

AAM White Paper: Ensuring the Future of Accessible Medicines in the U.S.

Prescription for Savings Banner - Ariel

Jan 4, 2018 | Erica Klinger

6 Policy Solutions

Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents

Oct 12, 2017 | Erica Klinger

AAM White Paper: Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents

Bates White Whitepaper - CPI (Medicaid Generics Penalty)

Sep 18, 2017 | Erica Klinger

Bates-White Report: CPI-Based Medicaid Rebates Harm Generic Competition

Generic Medicines

Aug 22, 2017 | Erica Klinger

Poll Results: California Proposed Drug Pricing Law (SB 17)

2017 Generic Drug Access and Savings Report Cover

Jul 25, 2017 | Erica Klinger

2017 Generic Drug Access and Savings Report

2016 AAM Annual Report

Jul 20, 2017 | Rebecca Rodrigues

2016 Annual Report